CytoMed Therapeutics Ltd

Ownership Transactions Reported by 10 Insiders

Symbol
GDTC on Nasdaq
Location
#08 22 One Commonwealth, 1 Commonwealth Lane, Singapore

There are no Buy or Sell transactions made by insiders since 9/19/2023

CytoMed Therapeutics Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lucas Tien Wee Luk Chief Clinical Officer, Director Mar 31, 2023
Keng Kiat Toh Director Mar 31, 2023
Jieming Zeng CSO and CMO, Director Mar 31, 2023
Shu Wang 10%+ Owner Mar 31, 2023
Mark Kei Wei Leong Director Mar 31, 2023
Chee Kong Choo Director, 10%+ Owner Mar 31, 2023
Glorious Finance Ltd 10%+ Owner Mar 31, 2023
Wee Kiat Tan Chief Operating Officer, Director Mar 31, 2023
Chak Hua Yew Director Mar 31, 2023
Yuin Han Loh Director Mar 31, 2023

There are no transactions filed by insiders of CytoMed Therapeutics Ltd